NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals, Inc. (OTC BB:SGYP) is pleased to announce that on August 21, 2008, the Board of Directors of Synergy Pharmaceuticals, Inc. appointed Melvin K. Spigelman, M.D. as a director of the Company. In addition, the Board of Directors appointed Dr. Spigelman Chairman of the Company’s Clinical Oversight Committee as well as a member of the Compensation Committee.
